FNY Partners Fund’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

FNY Partners Fund’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,329	Closed	-$31K	–	1484
2017 Q1	$31K	Buy	+1,329	New	+$29.8K	﹤0.01%	850

FNY Partners Fund's ARIA Position: Q2 2017 in Review

FNY Partners Fund sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2017, closing a stake of 1,428,547 shares — an estimated $34.3M sold.

FNY Partners Fund first reported a position in ARIA in Q1 2017 and held it in 1 quarter. The position peaked at $34.3M in Q1 2017. 0 funds tracked by Wall St. Rank hold ARIA as of Q2 2017.

FNY Partners Fund reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2017 after selling out during the quarter.
FNY Partners Fund sold 1,428,547 Ariad Pharmaceuticals Inc shares in Q2 2017, an estimated $34.3M.
FNY Partners Fund first reported a position in Ariad Pharmaceuticals Inc in Q1 2017 and held it in 1 quarter.
FNY Partners Fund's Ariad Pharmaceuticals Inc position peaked at $34.3M in Q1 2017.
0 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.